March 14, 2013 Schedule

Session 1: Epigenetics (8:00 am to 10:00 am)
Moderator
Rama Natarajan, Ph.D. (City of Hope, Duarte, CA)

Rodent models of epigenetic regulation of insulin resistance and diabetes
Rebecca Simmons, M.D.(Children's Hospital of Philadelphia, Philadelphia, PA)

 

Epigenomics of development and disease
Dustin Schones, Ph.D. (City of Hope, Duarte, CA)

 

Epigenetic regulation of alpha vs. beta cells
Anil Bhushan, Ph.D.(UCLA, Los Angeles, CA)

Beyondgenetics: The epigenetic code in chronic diabetic kidney disease
Dominic Raj, M.D. (George Washington University, Washington, DC)

Plenary Lecture (10:15 am to 10:45 am)
FoXO1, insulin action and metabolic effects
Domenico Accili, M.D.(Columbia University, New York, NY)

Session 2:Diabetes and the gut microbiome (11:00 am to 12:35 pm)
Moderator
Olle Korsgren, M.D., Ph.D. (Uppsala University Hospital, Uppsala, Sweden)

 

Bacteria reflux talk contributing to T1D
Olle Korsgren, M.D.,Ph.D.(Uppsala University Hospital, Uppsala, Sweden)

 

Fecal transplant talk – bridging T1D and T2D
Max Nieuwdorp, M.D., Ph.D.(Academic Medical Center-UvA, Amsterdam, The Netherlands)

 

Stopping autoimmune disease in type 1 diabetes: Exploiting the gut immune system
Chantal Mathieu, M.D., Ph.D. (Katholieke Universiteit, Leuven, Belgium)

Session 3: Islet imaging (2:00 pm to 4:00 pm)
Moderators
Al Powers, M.D.(Vanderbilt University, Nashville, TN)

 

The status of human beta cell specific monoclonal antibodies
Markus Grompe, M.D. (Oregon Health & Science University, Portland, OR)

Bioluminescent imaging of human pancreas islets
Jack Virostko, Ph.D.(Vanderbilt University, Nashville, TN)

 

Beta cell-specific imaging with zinc probes
A. Dean Sherry, Ph.D.(UT Southwestern, Dallas, TX)

 

VMAT2 ligand imaging of human beta cells in vivo
Gary Cline, Ph.D.(Yale University, New Haven, CT)

 

Poster Session (4:00 pm to 6:00 pm)